IP Library Granted Patent US 9,932,577
Granted Patent B2
US 9,932,577 · App. 14/066,334 · Granted Apr 3, 2018

Methods for multiplexing recombinase polymerase amplification

Inventors: Olaf Piepenburg (Hertfordshire, GB); Colin H. Williams (London, GB); Niall A. Armes (Essex, GB)
Assignee: ALERE SAN DIEGO, INC.
C12N15/113C12Q1/6804C12Q1/6816C12Q1/6827C12Q1/6844C12Q1/6853G01N21/78G01N33/558G01N2021/7759G01N2021/7763G01N2021/7793
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,932,577
App. No.
14/066,334
Granted
Apr 3, 2018
Kind
B2
Abstract

This disclosure provides for methods and reagents for rapid multiplex RPA reactions and improved methods for detection of multiplex RPA reaction products. In addition, the disclosure provides new methods for eliminating carryover contamination between RPA processes.

Claims (18)

1. A composition comprising:

(a) at least one recombinase;

(b) at least one polymerase;

(c) a target nucleic acid;

(d) a first and a second nucleic acid primer; and

(e) an extension blocked oligonucleotide which comprises

an elongation blocking group at the 3′ end;

at least one internal residue non-complementary to the target nucleic acid;

a modified internal residue selected from the group consisting of a tetrahydrofuran residue and a D-spacer; and

a fluorophore and a quencher.

2. The composition of claim 1 , further comprising a nuclease.

3. The composition of claim 2 , wherein the nuclease is a DNA glycosylase or AP endonuclease.

4. The composition of claim 1 , wherein the at least one internal residue is a uracil or inosine residue.

5. The composition of claim 1 , wherein the elongation blocking group at the 3′ end prevents polymerase extension.

6. The composition of claim 1 , wherein the at least one recombinase is in contact with at least one primer.

7. The composition of claim 1 , further comprising a crowding agent.

8. The composition of claim 1 , further comprising a single strand binding protein and/or a recombinase loading protein.

9. The composition of claim 8 , wherein the recombinase is UvsX, the single strand binding protein is gp32, and the recombinase loading protein is UvsY.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2020
From: ALERE SAN DIEGO INC.
To: ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Reel/Frame 054604/0936 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY RECORDED AT REEL 036994, FRAME 0192 AND REEL 037115, FRAME 0498 Recorded Oct 5, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS COLLATERAL AGENT
To: ALERE CONNECT, LLC; ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.); ALERE SCARBOROUGH, INC. (FKA MATRITECH, INC. FKA ADVANTAGE DIAGNOSTICS CORP. OR FKA BINAX, INC. OR FKA MILANO ACQUISITION CORP.); INNOVACON, INC. (FKA APPLIED BIOTECH, INC. OR FKA AMEDITECH INC.); IONIAN TECHNOLOGIES, LLC (FKA IONIAN TECHNOLOGIES, INC.); QUALITY ASSURED SERVICES INC. (FKA ZYCARE INC.); STANDING STONE, LLC; ESCREEN, INC.
Reel/Frame 044213/0258 →
ASSIGNMENT OF IP SECURITY AGREEMENT, PREVIOUSLY RECORDED AT REEL 036994, FRAME 0192 Recorded Nov 16, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING ADMINISTRATIVE AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR ADMINISTRATIVE AGENT
Reel/Frame 037115/0498 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 29, 2015
From: ALERE CONNECT, LLC; ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.); ALERE SCARBOROUGH, INC. (FKA MATRITECH, INC. FKA ADVANTAGE DIAGNOSTICS CORP. OR FKA BINAX, INC. OR FKA MILANO ACQUISITION CORP.); INNOVACON, INC. (FKA APPLIED BIOTECH, INC. OR FKA AMEDITECH INC.); IONIAN TECHNOLOGIES, LLC (FKA IONIAN TECHNOLOGIES, INC.); QUALITY ASSURED SERVICES INC. (FKA ZYCARE INC.); STANDING STONE, LLC; ESCREEN, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 036994/0192 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2013
From: PIEPENBURG, OLAF; WILLIAMS, COLIN H.; ARMES, NIALL A.
To: ASM SCIENTIFIC, INC.
Reel/Frame 031508/0400 →
CHANGE OF NAME Recorded Oct 30, 2013
From: BIOSITE INCORPORATED
To: ALERE SAN DIEGO, INC.
Reel/Frame 031515/0299 →
MERGER Recorded Oct 30, 2013
From: TWISTDX, INC.
To: BIOSITE INCORPORATED
Reel/Frame 031508/0670 →
CHANGE OF NAME Recorded Oct 30, 2013
From: ASM SCIENTIFIC, INC
To: TWISTDX, INC.
Reel/Frame 031508/0498 →
Continuity (5)
Continuation 13177007 · Jul 6, 2011
Continuation 11988825
Provisional Application 60702533 · Jul 25, 2005
Provisional Application 60728424 · Oct 18, 2005
Related Publication 20140295436A1 · Oct 2, 2014